Consumer group cries foul over GOP's 2013 budget

Share this article:
Rep. Paul Ryan (R-WI)
Rep. Paul Ryan (R-WI)

The fiscal 2013 budget, which was passed in the House, would cause seniors' healthcare costs to surge and wreak havoc on Medicare and Medicaid, two new reports suggest.

The budget, which was engineered by Rep. Paul Ryan (R-WI) and is expected to hit a dead end in the Senate, would cut Medicare and Medicaid spending by roughly $2.75 trillion over 10 years, according to two reports released by the consumer advocacy group Families USA.

The Medicare reform measure, which would convert the program to a voucher-based premium support system for beneficiaries born after 1957, would reduce what beneficiaries receive by 23% within seven years of taking effect, according to the group.

The budget's proposed Medicaid cuts — in addition to calling for repeal of the Affordable Care Act provision expanding Medicaid eligibility — would transfer the program into a block grant program. Families USA says this “would not address healthcare spending in any rational, thoughtful way that would lead to long-term, sustainable deficit reduction.”

The report was released in two parts. Click here for the report titled “The Republican Budget Proposal: Ending Medicare As We Know It? Again,” and here to read “Republicans Again Propose Slashing Funding for Medicaid, Medicare, and Other Health Programs.”

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.